ALLIANCE A071401 Primary Category: Treatment Protocols Disease Category: Brain Status: Open Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas with SMO/ AKT/ NF2/CDK Pathway Mutations NCT#02523014 (Click for More Info)